Futile effort, but ... | BMY Message Board Posts


Bristol-Myers Squibb Co.

  BMY website

BMY   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  12072 of 12445  at  12/4/2023 2:10:20 PM  by

Biotech2050

The following message was updated on 12/4/2023 2:11:56 PM.

 In response to msg 12071 by  Doolen
view thread

Re: Futile effort, but ...

  
 Elkins is basically the number 2 of the company. Not sure that this is the right approach.
 
As ex Celgene holders we were accustomed to being the partner of choice for small and emerging biotech companies in a period were funding for these companies was readily available. 
 
Now most biotech companies are cash starved and yet BMY is not a partner of choice for these cash desperate companies.
 
This is where we should focus our criticism. At least that’s what i wrote to them in my personal name (never got an acknowledgment). 
BMY needs a multitude of XLRN type of deals. 
 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 1  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
12073 Re: Futile effort, but ... Doolen 2 12/4/2023 5:15:33 PM




Financial Market Data provided by
.
Loading...